Promising results of niraparib appear in patients with advanced melanoma

Researchers at Sutter’s California Pacific Medical Center (CPMC) in San Francisco, Calif. have discovered early signs of clinical benefit while testing niraparib, a PARP inhibitor, in patients with advanced melanoma whose tumors had specific genetic changes impacting DNA repair.

Go to Source
https://medicalxpress.com/rss-feed/

Top